WallStreetZenWallStreetZen

NASDAQ: CNTB
Connect Biopharma Holdings Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Connect Biopharma Holdings earnings were -$46.4M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest CNTB earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$12.9M, up 25.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNTB reported annual earnings of -$15.6M, with -74.8% growth.

CNTB earnings history

Current Revenue
$2.0M
Current Earnings
-$46.4M
Current Profit Margin
-2,363.8%

CNTB Return on Equity

Current Company
-51.1%
Current Industry
-10%
Current Market
30.7%
CNTB's Return on Equity (-51.1%)... subscribe to Premium to read more.
High Return on Equity Performance

CNTB undefined

Current Company
-45.7%
Current Industry
-0.2%
CNTB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CNTB announces earnings.

CNTB undefined

Current Company
-64.16%
Current Industry
6.4%
CNTB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNTB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CNTBN/A-$46.45MN/A-$0.84
ATYR-$62.26M-$63.41MN/A-$0.80
WHWK$28.33M$27.61M-52.41%$0.16
DOMH-$18.50M-$19.02MN/A-$2.38
OVID-$36.47M-$38.18MN/A-$0.53
View Top Biotech Stocks

Connect Biopharma Holdings Earnings Reports & History FAQ

What were Connect Biopharma Holdings's earnings last quarter?

Connect Biopharma Holdings (NASDAQ: CNTB) reported Q2 2025 earnings per share (EPS) of -$0.23, up 185.19% year over year. Total CNTB earnings for the quarter were -$12.90 million. In the same quarter last year, Connect Biopharma Holdings's earnings per share (EPS) was $0.27.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.

Is Connect Biopharma Holdings profitable or losing money?

As of the last Connect Biopharma Holdings earnings report, Connect Biopharma Holdings is currently losing money. Connect Biopharma Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$46.45 million, a 82.31% increase year over year.

What was CNTB's earnings growth in the past year?

As of Connect Biopharma Holdings's earnings date in Q3 2025, Connect Biopharma Holdings's earnings has grown year over year. CNTB earnings in the past year totalled -$46.45 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.